启明星 | 中国显示芯片设计领军企业云英谷科技成功登陆香港交易所 | Bilingual
早在2019年，启明创投领投云英谷C轮融资，并在后续D轮融资中持续支持公司发展
** Swipe Left for the English Version**
北京时间2026年5月27日，**启明创投投资企业、中国显示芯片设计领军企业云英谷科技成功登陆港交所，至此启明创投迎来开年第六个IPO。**云英谷科技（03310.HK）发行价为20.81港元/股，开盘价25.48港元/股，市值109亿港元。
早在2019年，启明创投领投云英谷科技C轮融资，并在后续D轮融资中持续支持公司发展。
启明创投主管合伙人周志峰（左）、云英谷科技董事长兼CEO顾晶（中）与启明创投执行董事陈南（右）
云英谷科技成立于2012年，致力于为消费电子品牌公司提供可靠及高性能的显示驱动方案。公司采用Fabless业务模式，提供主要应用于智能手机的AMOLED显示驱动芯片和主要应用于VR/AR设备的Micro-OLED显示背板/驱动。 经过多年技术积累与产品迭代，云英谷科技已稳居显示驱动芯片行业核心位置，不仅是中国大陆首家通过品牌客户认证的AMOLED显示驱动芯片企业，也是唯一一家对品牌公司累计出货量超过千万颗的大陆厂商。
云英谷科技AMOLED显示驱动芯片已经向全球多家主流智能手机品牌厂商量产出货，应用于超10个产品系列，合作品牌合计占据全球智能手机市场份额四分之一以上。 根据弗若斯特沙利文报告显示，按照2024年销量计算，云英谷科技是全球智能手机AMOLED显示驱动芯片市场的第五大供应商，同时也是中国大陆最大的供应商。Micro-OLED显示背板/驱动的销售量位列全球第二，同时也是该领域中总部位于中国的规模最大的独立供应商。
启明创投主管合伙人周志峰表示："2019年，中国半导体产业正迎来高速成长期，同时中国手机产业登上全球领导地位，沿着下游终端需求向上溯源，显示芯片赛道具备极强的产业逻辑与成长空间。而云英谷科技当时聚焦显示驱动芯片主业，高度契合我们的投资逻辑，也是当时我们十分看好的优质细分赛道。与云英谷科技携手同行的七年里，启明创投以长期主义姿态一路相伴，共同支撑企业走到IPO。时至今日，启明创投的投资策略越来越聚焦，坚持深耕自身已构建的能力圈，踏踏实实地开展投资布局。在科技投资赛道，启明创投长期坚定两大核心投资主题：其一，人工智能作为通用目的技术（General Purpose Technology），必将重塑各行各业；其二，中国本土顶尖的产品设计、工程研发与先进制造实力，具备全球一流竞争力。依托这两大主线，我们会重点聚焦AI技术与产业应用、硬科技两大方向。"
Domestic Display Chip Leader Viewtrix Technology Listed on Hong Kong Stock Exchange
Viewtrix Technology, a portfolio company of Qiming Venture Partners and a leading display chip design enterprise in China, successfully listed on the Hong Kong Stock Exchange, marking the sixth IPO for Qiming Venture Partners since the beginning of the year. Viewtrix Technology (03310.HK) offered its shares at a price of HK$20.81 per share and opened at HK$25.48 per share with a market capitalization of HK$10.9 billion.
As early as 2019, Qiming Venture Partners led the Series C financing of Viewtrix Technology and continued to support the company's development in the subsequent Series D financing.
Founded in 2012, Viewtrix Technology is committed to providing reliable and high-performance display driver solutions for consumer electronics brands. Adopting a Fabless business model, the company offers AMOLED display driver chips mainly for smartphones and Micro-OLED display backplanes/drivers mainly for VR/AR devices. With years of technological accumulation and product iteration, Viewtrix Technology has firmly established itself as a key player in the display driver chip industry. It is not only the first company based in Chinese mainland to receive brand company certification for AMOLED DDICs, but also the only one to have shipped over 10 million units to these companies.
Viewtrix Technology's AMOLED DDICs have been mass-produced and delivered to various top smartphone companies globally featuring in over 10 different product series. These smartphone companies collectively hold more than a quarter of the global market share. According to Frost & Sullivan, Viewtrix Technology is the fifth-largest supplier, and the largest Chinese mainland-based supplier, in the global smartphone AMOLED DDIC market in terms of sales volume in 2024. In addition, Viewtrix Technology is a key supplier in the Micro-OLED display backplane/driver, ranking second in global sales volume, and it is also the largest independent supplier headquartered in China in this field.
Alex Zhou, Managing Partner of Qiming Venture Partners stated: "In 2019, China's semiconductor industry was entering a period of rapid growth, and China's mobile phone industry had taken a leading position globally. Tracing upstream from downstream terminal demand, the display chip sector featured strong industrial logic and growth potential. Back then, Viewtrix Technology focused on the core business of display driver chips, which highly aligned with our investment thesis and represented a promising niche segment we were very optimistic about. During the seven years partnering with Viewtrix Technology , Qiming Venture Partners has stood by the company with a long-term mindset, supporting it all the way to its IPO. Today, Qiming Venture Partners maintains an increasingly focused investment strategy, sticking to our proven circle of competence and steadily executing our investment layout. In the technology investment sector, Qiming Venture Partners has long been committed to two core investment themes: First, artificial intelligence, as a General Purpose Technology, will surely reshape all industries. Second, China's world-class capabilities in product design, engineering R&D, and advanced manufacturing deliver global competitiveness. Anchored by these two themes, we will focus on two key areas: AI technology and industrial applications, and hard tech."
7个月5个人工智能IPO，启明创投：投资AI是未来二十年中国投资最大的确定性
启明周报 | 启明创投投资企业要闻十条 Vol.17, 2026.5.26
启明创投成立于2006年。目前，启明创投旗下管理11只美元基金，7只人民币基金，已募管理资产总额达到95亿美元。自成立至今，专注于投资科技(Technology)、医疗创新(Healthcare)等行业早期和成长期的优秀企业。
截至目前，启明创投已投资超过580家高速成长的创新企业，其中有超过210家分别在美国纽交所、纳斯达克，香港交易所，上交所及深交所等交易所上市，或通过并购等方式退出，有80多家企业成为行业公认的独角兽或超级独角兽企业。
启明创投投资企业中，很多已经成长为各自领域中最具影响力的公司，包括小米集团（01810.HK）、美团（03690.HK）、哔哩哔哩（NASDAQ:BILI, 09626.HK）、知乎（NYSE:ZH, 02390.HK）、石头科技（688169.SH）、禾赛科技（NASDAQ：HSAI,02525.HK)、优必选（09880.HK）、文远知行（NASDAQ:WRD,0800.HK）、海博思创（688411.SH）、影石创新（688775.SH）、云知声（09678.HK）、壁仞科技（06082.HK）、智谱（02513.HK）、甘李药业（603087.SH）、泰格医药（300347.SZ, 03347.HK）、再鼎医药（NASDAQ:ZLAB, 09688.HK）、康希诺生物（688185.SH, 06185.HK）、Schrödinger（NASDAQ:SDGR）、惠泰医疗（688617.SH）、三友医疗（688085.SH）、艾德生物（300685.SZ）、神州细胞（688520.SH）、英矽智能（03696.HK）、浩博医药、圆心科技、宜联生物、礼新医药、阶跃星辰等。